The NextGen Clinical Trial Investigator Training is a virtual five-session educational program designed for investigators who currently lead or would like to lead clinical trials. The series includes lectures and panel discussions from leaders across the University of Missouri System, as well as Washington University, to define the regulatory, operational and ethical components of clinical trials, with the goal of developing a skilled workforce that provides the highest level of patient safety, teamwork and data quality. The program also covers institution-specific resources for investigators.

Timeframe: Five weeks, starting April 5 through May 3

• 5-6:30 p.m. - session program
• Additional videos to view to complete coursework

Follow the links below for speaker information at each session.

April 5 - Session 1: What is a Clinical Trial & Patient Perspective
April 12 - Session 2: Audit Ready Trials & Lessons Learned
April 19 - Session 3: Patient Recruitment & Informed Consent
April 26 - Session 4: Responsible Conduct of Research & Organizing Your Study Team
May 3 - Session 5: Institutional Resources

Session 3: Patient Recruitment & Informed Consent

		Study Start up—Hasan Naqvi, MD, Chief Medical Officer; Professor of Clinical Medicine; Medical Director, Clinical Research Center
		Good Clinical Practice—Mary Christie, Senior Director of Education Programs-Health Affairs, MU
		Sources of Bias & Error—J. Philip Miller, PhD, Professor of Biostatistics and Medicine, Institute for Informatics, Washington University in St. Louis
		Informed Consent—Hasan Naqvi, MD, Chief Medical Officer; Professor of Clinical Medicine; Medical Director, Clinical Research Center, MU
		Patient Recruitment—Suresh Vedantham, MD, Professor of Radiology and Assistant Dean for Clinical Research, Washington University in St. Louis, and Patricia Nieters, RN, Clinical Research Nurse Coordinator, Washington University in St. Louis